Research Topic

AstraZeneca expects to manufacture up to 3 billion doses of a COVID-19 vaccine in 2021 on a rolling basis, pending regulatory approval.

Royal Oils by Head & Shoulders and Gold Series from Pantene have partnered on the Rooted in Science Scholarship, which will be awarded to Black women pursuing a degree in STEM.

Pfizer said it plans to submit an application for emergency use authorization of its COVID-19 vaccine to the FDA within days.

Designed for those with sensitivities, the collection was created to eliminate irritants, harmful emissions and toxic residues, the company said.

EnsembleIQ, parent company of Drug Store News, wants to know what readers think of the retail industry's handling of diversity and inclusion.

Eli Lilly's bamlanivimab has received the Food and Drug Administration’s nod for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients.

Pfizer said that its vaccine candidate has shown more than 90% efficacy in preventing COVID-19 among participants who had not previously been infected with SARS-CoV-2 in the first interim efficacy analysis.